Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 230

1.

ΜelanoQ: A Consensus Questionnaire of Standardized Epidemiologic and Clinical Variables for Melanoma Risk Assessment by the MelaNostrum Consortium.

Stratigos AJ, Fargnoli MC, De Nicolo A, Peris K, Puig S, Soura E, Menin C, Calista D, Ghiorzo P, Mandala M, Massi D, Rodolfo M, Del Regno L, Stefanaki I, Gogas H, Bataille V, Tucker MA, Whiteman D, Nagore E, Landi MT.

J Eur Acad Dermatol Venereol. 2018 Aug 10. doi: 10.1111/jdv.15208. [Epub ahead of print]

PMID:
30098061
2.

Suitability of melanoma FFPE samples for NGS libraries: time and quality thresholds for downstream molecular tests.

Millán-Esteban D, Reyes-García D, García-Casado Z, Bañuls J, López-Guerrero JA, Requena C, Rodríguez-Hernández A, Traves V, Nagore E.

Biotechniques. 2018 Aug;65(2):79-85. doi: 10.2144/btn-2018-0016.

3.

TERT promoter mutation subtypes and survival in stage I and II melanoma patients.

Andrés-Lencina JJ, Rachakonda S, García-Casado Z, Srinivas N, Skorokhod A, Requena C, Soriano V, Kumar R, Nagore E.

Int J Cancer. 2018 Aug 2. doi: 10.1002/ijc.31780. [Epub ahead of print]

PMID:
30070694
4.

Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma.

Gu F, Chen TH, Pfeiffer RM, Fargnoli MC, Calista D, Ghiorzo P, Peris K, Puig S, Menin C, De Nicolo A, Rodolfo M, Pellegrini C, Pastorino L, Evangelou E, Zhang T, Hua X, DellaValle CT, Timothy Bishop D, MacGregor S, Iles MI, Law MH, Cust A, Brown KM, Stratigos AJ, Nagore E, Chanock S, Shi J; Melanoma Meta-Analysis Consortium; MelaNostrum Consortium, Landi MT.

Hum Mol Genet. 2018 Jul 30. doi: 10.1093/hmg/ddy282. [Epub ahead of print]

PMID:
30060076
5.

Sleep-Disordered Breathing is Independently Associated with Increased Aggressiveness of Cutaneous Melanoma. A multicentre observational study in 443 patients.

Martinez-Garcia MA, Campos-Rodriguez F, Nagore E, Martorell A, Rodriguez-Peralto JL, Riveiro-Falkenbach E, Hernandez L, Bañuls J, Arias E, Ortiz P, Cabriada V, Gardeazabal J, Montserrat JM, Carreres C, Corral J, Masa JF, Gomez de Terreros J, Abad J, Boada A, Mediano O, de Eusebio E, Chiner E, Landete P, Mayos M, Fortuño A, Barbé F, Sánchez de la Torre M, Sanchez de la Torre A, Cano I, Gonzalez C, Pérez-Gil A, Gómez-García T, Cullen D, Somoza M, Formigón M, Aizpuru F, Navarro C, Selma-Ferrer MJ, Garcia-Ortega A, de Unamuno B, Almendros I, Farré R, Gozal D.

Chest. 2018 Jul 27. pii: S0012-3692(18)31109-7. doi: 10.1016/j.chest.2018.07.015. [Epub ahead of print]

PMID:
30059679
6.

Experience With Vismodegib in the Treatment of Advanced Basal Cell Carcinoma at a Cancer Center.

Bernia E, Llombart B, Serra-Guillén C, Bancalari B, Nagore E, Requena C, Calomarde L, Diago A, Lavernia J, Traves V, Guillén C, Sanmartín O.

Actas Dermosifiliogr. 2018 Jul 25. pii: S0001-7310(18)30318-1. doi: 10.1016/j.ad.2018.06.003. [Epub ahead of print] English, Spanish.

PMID:
30055751
7.

Telomere length and survival in primary cutaneous melanoma patients.

Rachakonda S, Srinivas N, Mahmoudpour SH, Garcia-Casado Z, Requena C, Traves V, Soriano V, Cardelli M, Pajnova D, Molven A, Gruis N, Nagore E, Kumar R.

Sci Rep. 2018 Jul 19;8(1):10947. doi: 10.1038/s41598-018-29322-9.

8.

A randomized intraindividual comparative study of methyl-5-aminolaevulinate versus 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) in photodynamic therapy for actinic keratosis of the face and scalp.

Serra-Guillén C, Nagore E, Bancalari E, Kindem S, Sanmartín O, Llombart B, Requena C, Serra-Guillén I, Calomarde L, Diago A, Bernia E, Guillén C.

Br J Dermatol. 2018 Jul 17. doi: 10.1111/bjd.17014. [Epub ahead of print]

PMID:
30019337
9.

Intermittent Hypoxia Is Associated With High Hypoxia Inducible Factor-1α but Not High Vascular Endothelial Growth Factor Cell Expression in Tumors of Cutaneous Melanoma Patients.

Almendros I, Martínez-García MÁ, Campos-Rodríguez F, Riveiro-Falkenbach E, Rodríguez-Peralto JL, Nagore E, Martorell-Calatayud A, Hernández Blasco L, Bañuls Roca J, Chiner Vives E, Sánchez-de-la-Torre A, Abad-Capa J, Montserrat JM, Pérez-Gil A, Cabriada-Nuño V, Cano-Pumarega I, Corral-Peñafiel J, Diaz-Cambriles T, Mediano O, Dalmau-Arias J, Farré R, Gozal D; Spanish Sleep Network.

Front Neurol. 2018 Apr 26;9:272. doi: 10.3389/fneur.2018.00272. eCollection 2018.

10.

Lymph Node Dissection in Patients With Melanoma and Sentinel Lymph Node Metastasis: An Updated, Evidence-Based Decision Algorithm.

Moreno-Ramírez D, Boada A, Ferrándiz L, Samaniego E, Carretero G, Nagore E, Redondo P, Ortiz-Romero P, Malvehy J, Botella-Estrada R; miembros del Grupo Español de Dermato-Oncología y Cirugía. Academia Española de Dermatología y Venereología.

Actas Dermosifiliogr. 2018 Jun;109(5):390-398. doi: 10.1016/j.ad.2018.02.008. Epub 2018 Apr 9. English, Spanish.

PMID:
29650221
11.

Dysplastic vs. Common Naevus-associated vs. De novo Melanomas: An Observational Retrospective Study of 1,021 Patients.

Martin-Gorgojo A, Requena C, Garcia-Casado Z, Traves V, Kumar R, Nagore E.

Acta Derm Venereol. 2018 Jun 8;98(6):556-562. doi: 10.2340/00015555-2908.

12.

CDKN2A germline alterations in melanoma patients with personal or familial history of pancreatic cancer.

De Unamuno B, García-Casado Z, Bañuls J, Requena C, Lopez-Guerrero JA, Nagore E.

Melanoma Res. 2018 Jun;28(3):246-249. doi: 10.1097/CMR.0000000000000442.

PMID:
29543703
13.

Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea.

Santamaria-Martos F, Benítez I, Girón C, Barbé F, Martínez-García MA, Hernández L, Montserrat JM, Nagore E, Martorell A, Campos-Rodriguez F, Corral J, Cabriada V, Abad J, Mediano O, Troncoso MF, Cano-Pumarega I, Fortuna Gutierrez AM, Diaz-Cambriles T, Somoza-Gonzalez M, Almendros I, Farre R, Gozal D, Sánchez-de-la-Torre M; Spanish Sleep Network.

Eur Respir J. 2018 Mar 15;51(3). pii: 1701885. doi: 10.1183/13993003.01885-2017. Print 2018 Mar.

PMID:
29519923
14.

Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.

Huerta C, Garcia-Casado Z, Bañuls J, Moragon M, Oliver V, Unamuno B, Requena C, Kumar R, Nagore E.

Acta Derm Venereol. 2018 Apr 27;98(5):512-516. doi: 10.2340/00015555-2898.

15.

Chronology of regional lymph node metastases in cutaneous melanoma: a model based on mitotic rate.

Tejera-Vaquerizo A, Meléndez JJ, Nagore E.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e289-e291. doi: 10.1111/jdv.14824. Epub 2018 Feb 19. No abstract available.

PMID:
29377314
16.

The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil.

Armengot-Carbó M, Nagore E, García-Casado Z, Botella-Estrada R.

J Am Acad Dermatol. 2018 May;78(5):920-926.e4. doi: 10.1016/j.jaad.2017.12.064. Epub 2018 Jan 4.

PMID:
29307636
17.

ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression.

Kohli JS, Mir H, Wasif A, Chong H, Akhras V, Kumar R, Nagore E, Bennett DC.

Oncotarget. 2017 Nov 1;8(61):104408-104417. doi: 10.18632/oncotarget.22254. eCollection 2017 Nov 28.

18.

A 12-Day Course of Imiquimod 5% for the Treatment of Actinic Keratosis: Effectiveness and Local Reactions.

Serra-Guillén C, Nagore E, Llombart B, Sanmartín O, Requena C, Calomarde L, Guillén C.

Actas Dermosifiliogr. 2018 Apr;109(3):248-253. doi: 10.1016/j.ad.2017.10.008. Epub 2017 Dec 12. English, Spanish.

PMID:
29246367
19.

Cutaneous melanoma primary site is linked to nevus density.

Martin-Gorgojo A, Llinares M, Virós A, Requena C, Garcia-Casado Z, Traves V, Kumar R, Nagore E.

Oncotarget. 2017 Oct 24;8(58):98876-98886. doi: 10.18632/oncotarget.22016. eCollection 2017 Nov 17.

20.

Clinical assessment of skin phototypes: watch your words!

Trakatelli M, Bylaite-Bucinskiene M, Correia O, Cozzio A, De Vries E, Medenica L, Nagore E, Paoli J, Stratigos AJ, Del Marmol V, Bulliard JL.

Eur J Dermatol. 2017 Dec 1;27(6):615-619. doi: 10.1684/ejd.2017.3129.

Supplemental Content

Loading ...
Support Center